« Return to News | Study Conduct

University of Rochester Medical Center Creates Cardiac Safety Center

Wednesday, November 25, 2009 07:34 AM

The University of Rochester Medical Center announced the creation of a new center that will assist researchers studying the electrical activity of the heart with the goal of improving drug safety, understanding cardiac arrhythmias and developing new electrocardiograph technologies.

The Center for Quantitative Electrocardiology and Cardiac Safety—funded by a $2.3-million grant from the National Institutes of Health—brings together an international network of academic researchers, pharmaceutical and medical device companies and government regulators.

“Cardiac toxicity is one of the leading causes of removal of drugs from the market,” said University of Rochester biomedical engineer Jean-Philippe Couderc, Ph.D., the director of the new center. “The goal of this initiative is to foster collaboration on an international scale and support research that will ultimately improve cardiac safety.”

The new center will focus on developing novel methods and new technologies to evaluate electrocardiographs (ECG) for the purposes of predicting cardiac arrhythmias. The center will help scientists better understand heart disease and determine whether experimental drugs are toxic to the heart.

Sudden cardiac arrest is one of the leading causes of death and many of these incidents are drug-related—either caused by the drugs themselves or because a drug triggered a predisposition to lethal cardiac arrhythmias.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.